DIN 02223252 · ended Dec 24, 2019 · Disruption of the manufacture of the drug.
Showing 12 of 17 reports. All reports are on file with Health Canada.
What's happening
There are no active shortage reports for Esculin Framycetin Dibucaine Hydrocortisone. Health Canada has 17 historical reports on file for this drug, so supply has been disrupted before; the change log below shows the history.
Esculin Framycetin Dibucaine Hydrocortisone is classified under “AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE” (ATC C05AA).
Recent changes
No changes recorded yet.
Common questions
What is Esculin Framycetin Dibucaine Hydrocortisone used for?
A combination preparation used to relieve the discomfort of hemorrhoids.
When will Esculin Framycetin Dibucaine Hydrocortisone be back in stock in Canada?
Esculin Framycetin Dibucaine Hydrocortisone has no active shortage; supply is normal per Health Canada reports.
Why is Esculin Framycetin Dibucaine Hydrocortisone in shortage?
It isn't currently. Past reports and their reasons are listed above.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.